Compare ALKS & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | CAVA |
|---|---|---|
| Founded | 1987 | 2006 |
| Country | Ireland | United States |
| Employees | 2050 | 12900 |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 6.1B |
| IPO Year | 2012 | 2023 |
| Metric | ALKS | CAVA |
|---|---|---|
| Price | $45.24 | $53.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 28 |
| Target Price | $56.21 | ★ $81.83 |
| AVG Volume (30 Days) | 1.9M | ★ 2.6M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | ★ $1,475,899,000.00 | $1,179,664,000.00 |
| Revenue This Year | $23.57 | $27.36 |
| Revenue Next Year | $6.58 | $20.82 |
| P/E Ratio | ★ N/A | $132.83 |
| Revenue Growth | N/A | ★ 22.41 |
| 52 Week Low | $27.00 | $43.41 |
| 52 Week High | $55.67 | $98.79 |
| Indicator | ALKS | CAVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 50.69 |
| Support Level | $39.41 | $50.17 |
| Resistance Level | $45.20 | $55.31 |
| Average True Range (ATR) | 1.39 | 2.44 |
| MACD | 0.62 | 0.13 |
| Stochastic Oscillator | 96.63 | 56.77 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Cava is an emerging fast-casual restaurant chain with $1.2 billion in sales across 439 US company-owned units in 2025. The firm derives most of its revenue from the sale of Mediterranean- and Greek-inspired customizable bowls, salads, pita wraps, and beverages, using an assembly-line format. Cava centrally prepares and manufactures the sauces and dips served in its restaurants and sold in grocery stores. All of Cava's revenue is in the US, with the majority of its footprint in the Southeast and Southwest.